SERUM INSTITUTE OF INDIA PVT. LTD.

Company Snapshot

Founded: 1966
Entity Type: Private
Region: India
Headquarter: Maharashtra, India
Key Geographics: India
Corporate Address: 212/2, Hadapsar, Off Soli Poonawalla Road, Pune 411028, Maharashtra India Tel. +91-20-2699-3900 www.seruminstitute.com

Company Overview

Serum Institute of India Pvt. Ltd. is a global vaccine manufacturer and distributor of over 1.5 billion doses globally. Its portfolio includes vaccines for polio, diphtheria, tetanus, pertussis, Hib, BCG, recombinant hepatitis B, measles, mumps, and rubella, as well as pneumococcal and COVID-19. These vaccines are used in the national immunization programs of approximately 170 countries worldwide.

SERUM INSTITUTE OF INDIA PVT. LTD. In Reports

Global Markets for Infectious Disease Treatments

BCC Research Market Analyst says global market for infectious disease treatments is expected to grow from $72.5 billion in 2025 and is projected to reach $101 billion by the end of 2030.

Nasal Vaccines: Global Markets and Pipeline Analysis

Global market for nasal vaccines is estimated to increase from $383.8 million in 2022 to reach $568.1 million by 2027, at a CAGR of 8.2% for 2022-27.

Pediatric Vaccines: Global Markets

BCC Research Market Report for Pediatric Vaccines. Global Pediatric Vaccines market trends, with market revenue and CAGRs through 2027.

Company's Business Segments

  • Product : Bacterial Vaccines, Coronavirus Disease (COVID-19) Vaccines, Human Diagnostics, Viral Vaccines, Polysaccharide Conjugate Vaccines, Influenza Vaccines, Anti Sera, Combination Vaccines, Uro-Oncology, Recombinant Products
  • Service : Manufacturing, Supply and Distribution, Clinical Development, Partnerships, Others

Applications/End User Industries

  • Healthcare
  • Pharmaceuticals
  • Research Institutes
AI Sentiment